This program features subject matter experts discussing key abstracts in an expansive variety of disease states such as lymphomas, acute and chronic lymphoblastic leukemias, myeloma and plasma cell dyscrasia, myeloproliferative neoplasms, red cell disorders, sickle cell disease, and immune hemolysis. It will provide the latest research as well as its application to clinical treatment. Participants will be able to discuss advances in clinical and translational hematology research; evaluate the role of new diagnostic techniques and therapeutic approaches as applied to the care and management of people with blood diseases, and implement new patient management and clinical applications, or revise existing ones to enhance the quality of patient care.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Specialties served/covered
- Anatomic & Clinical Pathology
- Blood Banking & Transfusion Medicine
- General Internal Medicine
- Hematology
- Hematopathology
- Medical Oncology
- Musculoskeletal Oncology
- Pediatric Hematology-Oncology
- Pediatric Transplant Hepatology
- GI & Liver
- Internal Medicine
- Oncology & Hematology
- Orthopedics
- Pathology & Lab
- No reviews yet. Be the first to share yours.
- Live
- Credit · Up to 13 credits
- MOC · Up to 13 points
- Paid · fee on provider site
- Commercial Support
-
WhenJan 22–23, 2027
